622 related articles for article (PubMed ID: 33117120)
1. Gangliosides in the Brain: Physiology, Pathophysiology and Therapeutic Applications.
Sipione S; Monyror J; Galleguillos D; Steinberg N; Kadam V
Front Neurosci; 2020; 14():572965. PubMed ID: 33117120
[TBL] [Abstract][Full Text] [Related]
2. Gangliosides as Therapeutic Targets for Neurodegenerative Diseases.
Inci OK; Basırlı H; Can M; Yanbul S; Seyrantepe V
J Lipids; 2024; 2024():4530255. PubMed ID: 38623278
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory role of GM1 and other gangliosides on microglia.
Galleguillos D; Wang Q; Steinberg N; Zaidi A; Shrivastava G; Dhami K; Daskhan GC; Schmidt EN; Dworsky-Fried Z; Giuliani F; Churchward M; Power C; Todd K; Taylor A; Macauley MS; Sipione S
J Neuroinflammation; 2022 Jan; 19(1):9. PubMed ID: 34991625
[TBL] [Abstract][Full Text] [Related]
4. Gangliosides in Neurodegenerative Diseases.
Ledeen R; Chowdhury S
Adv Neurobiol; 2023; 29():391-418. PubMed ID: 36255682
[TBL] [Abstract][Full Text] [Related]
5. Pathogenic role of ganglioside metabolism in neurodegenerative diseases.
Ariga T
J Neurosci Res; 2014 Oct; 92(10):1227-42. PubMed ID: 24903509
[TBL] [Abstract][Full Text] [Related]
6. Gangliosides of the Vertebrate Nervous System.
Schnaar RL
J Mol Biol; 2016 Aug; 428(16):3325-3336. PubMed ID: 27261254
[TBL] [Abstract][Full Text] [Related]
7. Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease--a review.
Ariga T; McDonald MP; Yu RK
J Lipid Res; 2008 Jun; 49(6):1157-75. PubMed ID: 18334715
[TBL] [Abstract][Full Text] [Related]
8. Gangliosides: Treatment Avenues in Neurodegenerative Disease.
Magistretti PJ; Geisler FH; Schneider JS; Li PA; Fiumelli H; Sipione S
Front Neurol; 2019; 10():859. PubMed ID: 31447771
[TBL] [Abstract][Full Text] [Related]
9. Imaging mass spectrometry allows for neuroanatomic-specific detection of gangliosides in the healthy and diseased brain.
Wang WX; Whitehead SN
Analyst; 2020 Apr; 145(7):2473-2481. PubMed ID: 32065183
[TBL] [Abstract][Full Text] [Related]
10. Ganglioside GM1 and the Central Nervous System.
Guo Z
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298512
[TBL] [Abstract][Full Text] [Related]
11. Gangliosides in nervous system development, regeneration, and pathologies.
Vasques JF; de Jesus Gonçalves RG; da Silva-Junior AJ; Martins RS; Gubert F; Mendez-Otero R
Neural Regen Res; 2023 Jan; 18(1):81-86. PubMed ID: 35799513
[TBL] [Abstract][Full Text] [Related]
12. The Pathogenic Role of Ganglioside Metabolism in Alzheimer's Disease-Cholinergic Neuron-Specific Gangliosides and Neurogenesis.
Ariga T
Mol Neurobiol; 2017 Jan; 54(1):623-638. PubMed ID: 26748510
[TBL] [Abstract][Full Text] [Related]
13. Gangliosides and glycolipids in neurodegenerative disorders.
Schneider JS
Adv Neurobiol; 2014; 9():449-61. PubMed ID: 25151391
[TBL] [Abstract][Full Text] [Related]
14. A critical role for GM1 ganglioside in the pathophysiology and potential treatment of Parkinson's disease.
Schneider JS
Glycoconj J; 2022 Feb; 39(1):13-26. PubMed ID: 34037912
[TBL] [Abstract][Full Text] [Related]
15. Gangliosides in Inflammation and Neurodegeneration.
Furukawa K; Ohmi Y; Tajima O; Ohkawa Y; Kondo Y; Shuting J; Hashimoto N; Furukawa K
Prog Mol Biol Transl Sci; 2018; 156():265-287. PubMed ID: 29747817
[TBL] [Abstract][Full Text] [Related]
16. Gangliosides--a new therapeutic agent against stroke and Alzheimer's disease.
Svennerholm L
Life Sci; 1994; 55(25-26):2125-34. PubMed ID: 7997071
[TBL] [Abstract][Full Text] [Related]
17. Disease-modifying effects of ganglioside GM1 in Huntington's disease models.
Alpaugh M; Galleguillos D; Forero J; Morales LC; Lackey SW; Kar P; Di Pardo A; Holt A; Kerr BJ; Todd KG; Baker GB; Fouad K; Sipione S
EMBO Mol Med; 2017 Nov; 9(11):1537-1557. PubMed ID: 28993428
[TBL] [Abstract][Full Text] [Related]
18. Lipid rafts: keys to neurodegeneration.
Schengrund CL
Brain Res Bull; 2010 Apr; 82(1-2):7-17. PubMed ID: 20206240
[TBL] [Abstract][Full Text] [Related]
19. Restoration of Adult Neurogenesis by Intranasal Administration of Gangliosides GD3 and GM1 in The Olfactory Bulb of A53T Alpha-Synuclein-Expressing Parkinson's-Disease Model Mice.
Fuchigami T; Itokazu Y; Morgan JC; Yu RK
Mol Neurobiol; 2023 Jun; 60(6):3329-3344. PubMed ID: 36849668
[TBL] [Abstract][Full Text] [Related]
20. Deciphering the glycolipid code of Alzheimer's and Parkinson's amyloid proteins allowed the creation of a universal ganglioside-binding peptide.
Yahi N; Fantini J
PLoS One; 2014; 9(8):e104751. PubMed ID: 25140899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
